Bulletin from the extraordinary general meeting on March 28, 2022, in SynAct Pharma AB
Today, on March 28, 2022, an extraordinary general meeting was held in SynAct Pharma AB. The meeting was held only by advance voting (postal vote) in accordance with temporary legislation. A summary of the adopted resolutions follows below. All resolutions were adopted with the required majority of votes.Election of new board member and remuneration for the new board member The meeting resolved, in accordance with the proposal from the Nomination Committee, to elect Kerstin Hasselgren as new ordinary board member for the time period up until the end of the next annual general meeting